Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience

Systemic chemotherapy or chemoradiotherapy is the initial primary option for patients with locally advanced pancreatic cancer (LAPC). This study analyzed the effect of FOLFIRINOX and assessed the factors influencing conversion to surgical resectability for LAPC. Sixty-four patients with LAPC who rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jongchan, Lee, Jong-chan, Gromski, Mark A., Kim, Hyoung Woo, Kim, Jinwon, Kim, Jaihwan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320053/
https://www.ncbi.nlm.nih.gov/pubmed/30558029
http://dx.doi.org/10.1097/MD.0000000000013592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320053/
https://www.ncbi.nlm.nih.gov/pubmed/30558029
http://dx.doi.org/10.1097/MD.0000000000013592

Ejemplares similares